Untitled Document
[an error occurred while processing this directive]
March 2012  
Untitled Document

IT @ Healthcare
North India Special
Hospital Infra
Technology for Healthier Lives
Trade & Trends
Healthcare Life


In Imaging

Contact Us
Media Kit
Network Sites
Express Computer
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
Indian Express
Financial Express

[an error occurred while processing this directive]

[an error occurred while processing this directive]

[an error occurred while processing this directive]

Home - Market - Article

Covidien's New R&D Centre in Hyderabad

The company intends to devote five to six per cent of sales to R&D activities in the next few years

Harry de Wit, President, Asia, Covidien lights the ceremonial lamp

Covidien, a global provider of healthcare products has opened its first R&D centre in India. Known as the Covidien India Engineering Center (CIEC), it is a 40,000 sq ft facility based in DLF Cybercity Special Economic Zone (SEZ), Hyderabad and will be expanded into a larger facility in the future. The CIEC offers a range of engineering services for the company’s medical products business and in the course of time could employ up to 350 staff members.

Randel Frazier, Vice President, R&D, Emerging Markets said, “Innovation is at the heart of everything Covidien does. The company devotes significant resources to invent and develop technology that physicians utilise to improve patient outcomes. Our company is expanding our R&D capabilities worldwide and this new facility in India is playing an integral role in our global strategy.”

Covidien has increased its R&D investments substantially in the last five years and has launched more than 100 new products. The company intends to devote five to six per cent of sales to R&D activities in the next few years.

CIEC will provide engineering services to Covidien’s R&D organisation in the areas of design, hardware, software and testing etc.

Robert Frechette, Vice President, Engineering Services, said, “India has a strong base of highly-talented engineers. Bringing this talent into Covidien’s organisation is critical for our continued growth. By establishing this presence in Hyderabad, we are expanding Covidien’s R&D capabilities as well as enhancing the city’s reputation as a hub for life sciences.”

“Our new facility is up and running with more than 30 engineers and staff involved in Covidien’s global R&D efforts,” added Frechette.

“With a fast-growing economy, the demand for healthcare in India is growing at a rapid pace,” said Arjun Sarker, Managing Director, Indian subcontinent. “The establishment of this R&D facility expands Covidien’s presence and commitment to India,” he said.

EH News Bureau


Untitled Document

FEEDBACK: We would love to hear from you -- what you like about our content, what you dont, and even how you think we can improve. Please send your feedback to: healthcare@expressindia.com

Copyright 2001: The Indian Express Limited. All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of The Indian Express Limited. Site managed by BPD.